Skip to main content
main-content

Aflibercept

News

07-04-2017 | Complications | News

June Cochrane review round-up

Here we provide an overview of the seven Cochrane reviews published in June that covered topics relating to diabetes, including glycemic control for prevention of renal failure, phototherapy for foot ulcers, and anti-vascular endothelial growth factor treatment for diabetic macular edema.

05-12-2017 | Aflibercept | News

Aflibercept has edge over laser retinopathy treatment in CLARITY trial

Results of the CLARITY trial suggest that aflibercept treatment may produce better visual outcomes than laser photocoagulation in patients with proliferative diabetic retinopathy.

05-09-2017 | Aflibercept | News

Anti-VEGF therapy can improve diabetic retinopathy

A substantial proportion of diabetes patients experience improvements in diabetic retinopathy while receiving anti-vascular endothelial growth factor treatment, shows the latest analysis from DRCR.net.

Read more

Related topics

Superior

Related

Opinion

08-22-2017 | Retinopathy | Editorial | Article

Antivascular endothelial growth factor treatment for proliferative diabetic retinopathy: Perspective on the CLARITY study

In this editorial, Rishi Singh and colleagues provide their perspective on the future of proliferative diabetic retinopathy treatment following the completion of the CLARITY and Protocol S studies.

Journal articles and book chapters

07-16-2015 | Retinopathy | Book chapter | Article

A basic scientific understanding of diabetic retinopathy

In: Managing Diabetic Eye Disease in Clinical Practice. Edited by Singh RP. Springer International Publishing, 2015. doi: 10.1007/978-3-319-08329-2_2

Authors:
Nathaniel Sears, Alex Yuan
image credits